ClinConnect ClinConnect Logo
Search / Trial NCT06988839

Effect Of Microneedling With Coronally Advanced Flap For Management of RT1 Gingival Recession In Thin Gingival Phenotype

Launched by POSTGRADUATE INSTITUTE OF DENTAL SCIENCES ROHTAK · May 23, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Gingival Recession Percutaneous Collagen Induction Root Coverage Connective Tissue Graft Microneedle

ClinConnect Summary

This clinical trial is investigating a new treatment for a specific type of gum recession known as RT1 gingival recession, which can occur in patients with thin gums. The researchers want to find out if a procedure called microneedling, followed by a surgical technique known as a coronally advanced flap, can help improve the thickness of gum tissue and successfully cover the exposed tooth roots. They will compare this combination approach with the traditional method that uses a tissue graft to see if both produce similar results for patients with thin gums.

To participate, eligible individuals should be between 20 and 50 years old, have a specific type of gum recession in the upper front teeth, and be generally healthy. They will need to commit to good oral hygiene and attend several appointments for treatment and follow-ups over the next six months. The trial is not yet recruiting, so there’s no immediate action required, but it aims to help improve gum health and aesthetic outcomes for those affected by this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Presence of isolated RT1 buccal maxillary gingival recessions in esthetic zone with thin gingival phenotype (Gingival thickness≤1mm) associated with esthetic complaints and/or dental sensitivity and otherwise systemically healthy.
  • Gingival Recession ≥2mm , Keratinized tissue width≥2mm and clinically identifiable cementoenamel junction
  • Age 20years-50 years
  • Patient demonstrating compliance for maintaining good oral hygiene after Phase 1 therapy Plaque index (PI) \<1, Gingival Index (GI) \<1
  • Providing a written and verbal informed consent.
  • Exclusion Criteria:
  • Patient with systemic disease that can influence the outcome of therapy.
  • Pregnant females or on oral contraceptive pills or hormone replacement therapy.
  • Smokers and patients undergoing orthodontic therapy
  • Physically and mentally impaired patients.
  • Non vital, malpositioned tooth
  • Presence of cervical abrasions or restorations in the area
  • Previous history of periodontal surgery on the involved sites.

About Postgraduate Institute Of Dental Sciences Rohtak

The Postgraduate Institute of Dental Sciences, Rohtak, is a premier academic institution dedicated to advancing dental education, research, and clinical practice. With a commitment to fostering innovation in oral health, the institute is actively engaged in conducting clinical trials that aim to enhance treatment methodologies and improve patient outcomes. By integrating cutting-edge research with comprehensive training, the institute plays a pivotal role in shaping the future of dental sciences, while adhering to the highest ethical standards and regulatory guidelines in clinical research.

Locations

Rohtak, Haryana, India

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported